Healthcare provider profile · identity verified

Vikramaditya Poonai, M.D.

Internal Medicine · CUMBERLAND, MD · NPI 1851477152

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Losartan Potassium	Losartan Potassium	777	207
Levothyroxine Sodium	Levothyroxine Sodium	748	197
Amlodipine Besylate	Amlodipine Besylate	656	181
Metoprolol Tartrate	Metoprolol Tartrate	573	162
Atorvastatin Calcium	Atorvastatin Calcium	462	133
Pantoprazole Sodium	Pantoprazole Sodium	391	117
Furosemide	Furosemide	311	108
Rosuvastatin Calcium	Rosuvastatin Calcium	296	89
Lisinopril	Lisinopril	241	63
Metoprolol Succinate	Metoprolol Succinate	240	74
Metformin Hcl	Metformin Hcl	199	59
Eliquis	Apixaban	192	49
Sertraline Hcl	Sertraline Hcl	190	48
Omeprazole	Omeprazole	179	56
Hydrochlorothiazide	Hydrochlorothiazide	158	48
Olmesartan Medoxomil	Olmesartan Medoxomil	150	41
Paroxetine Hcl	Paroxetine Hcl	147	42
Meloxicam	Meloxicam	144	57
Terazosin Hcl	Terazosin Hcl	142	41
Prednisone	Prednisone	135	83
Simvastatin	Simvastatin	135	46
Allopurinol	Allopurinol	133	40
Clopidogrel	Clopidogrel Bisulfate	128	35
Potassium Chloride	Potassium Chloride	127	38
Trazodone Hcl	Trazodone Hcl	122	40
Lovastatin	Lovastatin	120	29
Albuterol Sulfate Hfa	Albuterol Sulfate	118	58
Lorazepam	Lorazepam	118	37
Glipizide	Glipizide	117	36
Gabapentin	Gabapentin	111	36
Amoxicillin	Amoxicillin	107	80
Buspirone Hcl	Buspirone Hcl	105	36
Pravastatin Sodium	Pravastatin Sodium	102	28
Valsartan	Valsartan	100	28
Hydralazine Hcl	Hydralazine Hcl	97	27
Doxycycline Hyclate	Doxycycline Hyclate	95	67
Tamsulosin Hcl	Tamsulosin Hcl	91	22
Cefprozil	Cefprozil	88	71
Carvedilol	Carvedilol	82	24
Ezetimibe	Ezetimibe	79	23
Escitalopram Oxalate	Escitalopram Oxalate	76	21
Fluoxetine Hcl	Fluoxetine Hcl	76	21
Glimepiride	Glimepiride	73	21
Synthroid	Levothyroxine Sodium	72	21
Cephalexin	Cephalexin	71	61
Alprazolam	Alprazolam	69	16
Trulicity	Dulaglutide	68	11
Azithromycin	Azithromycin	67	54
Baclofen	Baclofen	63	35
Montelukast Sodium	Montelukast Sodium	62	23
Nifedipine Er	Nifedipine	61	18
Jardiance	Empagliflozin	58	14
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	55	44
Ozempic	Semaglutide	54	suppressed
Fluticasone Propionate	Fluticasone Propionate	51	19
Ciprofloxacin Hcl	Ciprofloxacin Hcl	50	37
Ropinirole Hcl	Ropinirole Hcl	48	13
Xarelto	Rivaroxaban	47	11
Digoxin	Digoxin	46	11
Esomeprazole Magnesium	Esomeprazole Magnesium	45	14
Hydroxyzine Hcl	Hydroxyzine Hcl	44	24
Lansoprazole	Lansoprazole	43	12
Naproxen	Naproxen	41	16
Nystatin	Nystatin	41	22
Atenolol	Atenolol	38	suppressed
Duloxetine Hcl	Duloxetine Hcl	38	12
Finasteride	Finasteride	35	suppressed
Ramipril	Ramipril	35	suppressed
Sucralfate	Sucralfate	35	14
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	34	14
Citalopram Hbr	Citalopram Hydrobromide	33	suppressed
Myrbetriq	Mirabegron	33	suppressed
Spironolactone	Spironolactone	33	11
Metformin Hcl Er	Metformin Hcl	32	11
Amiodarone Hcl	Amiodarone Hcl	31	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	31	11
Donepezil Hcl	Donepezil Hcl	30	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	29	suppressed
Mirtazapine	Mirtazapine	29	suppressed
Colchicine	Colchicine	28	14
Gemfibrozil	Gemfibrozil	28	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	28	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	27	20
Quetiapine Fumarate	Quetiapine Fumarate	27	suppressed
Dexlansoprazole Dr	Dexlansoprazole	26	11
Alendronate Sodium	Alendronate Sodium	25	suppressed
Januvia	Sitagliptin Phosphate	25	suppressed
Levetiracetam	Levetiracetam	25	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	25	25
Famotidine	Famotidine	24	suppressed
Ondansetron Hcl	Ondansetron Hcl	24	18
Warfarin Sodium	Warfarin Sodium	24	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	23	suppressed
Fluconazole	Fluconazole	22	18
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	22	suppressed
Ofloxacin	Ofloxacin	21	19
Mupirocin	Mupirocin	20	14
Oxybutynin Chloride Er	Oxybutynin Chloride	20	suppressed
Nyamyc	Nystatin	19	suppressed
Ondansetron Odt	Ondansetron	19	11
Pregabalin	Pregabalin	19	suppressed
Telmisartan	Telmisartan	19	suppressed
Azelastine Hcl	Azelastine Hcl	18	12
Celecoxib	Celecoxib	18	suppressed
Fenofibrate	Fenofibrate	18	suppressed
Glipizide Er	Glipizide	18	suppressed
Ramelteon	Ramelteon	18	suppressed
Tresiba Flextouch U-100	Insulin Degludec	18	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	17	suppressed
Memantine Hcl	Memantine Hcl	17	suppressed
Torsemide	Torsemide	17	suppressed
Bumetanide	Bumetanide	16	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	16	suppressed
Irbesartan	Irbesartan	16	suppressed
Chlorthalidone	Chlorthalidone	15	suppressed
Farxiga	Dapagliflozin Propanediol	15	suppressed
Midodrine Hcl	Midodrine Hcl	15	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	15	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	15	suppressed
Tradjenta	Linagliptin	15	suppressed
Tramadol Hcl	Tramadol Hcl	15	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	14	suppressed
Nitroglycerin	Nitroglycerin	14	suppressed
Enalapril Maleate	Enalapril Maleate	13	suppressed
Entresto	Sacubitril/Valsartan	13	suppressed
Lamotrigine	Lamotrigine	13	suppressed
Meclizine Hcl	Meclizine Hcl	13	suppressed
Methylprednisolone	Methylprednisolone	13	suppressed
Raloxifene Hcl	Raloxifene Hcl	13	suppressed
Acyclovir	Acyclovir	12	suppressed
Clonazepam	Clonazepam	12	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	12	suppressed
Enoxaparin Sodium	Enoxaparin Sodium	12	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	12	suppressed
Sulindac	Sulindac	12	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	12	suppressed
Ventolin Hfa	Albuterol Sulfate	12	suppressed
Bupropion Hcl Sr	Bupropion Hcl	11	suppressed
Hydrocortisone	Hydrocortisone	11	suppressed
Paxlovid (Eua)	Nirmatrelvir/Ritonavir	11	11

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error